Atyr Pharma Inc (NASDAQ:ATYR) price on current trading day, rose 5.51% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.87.
A look at the stock’s price movement, the close in the last trading session was $2.72, moving within a range at $2.53 and $2.975. The beta value (5-Year monthly) was 0.958. Turning to its 52-week performance, $4.66 and $1.42 were the 52-week high and 52-week low respectively. Overall, ATYR moved -6.51% over the past month.
Atyr Pharma Inc’s market cap currently stands at around $255.03 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
The average forecast suggests down to a -100.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2M, representing a 751.06% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATYR is a 50% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
ATYR’s current price about -13.88% and -18.85% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.68, while 7-day volatility ratio is 16.06% and 10.32% in the 30-day chart. Further, Atyr Pharma Inc (ATYR) has a beta value of 0.82, and an average true range (ATR) of 0.33.
If we refocus on Atyr Pharma Inc (NASDAQ:ATYR), historical trading data shows that trading volumes averaged 1.6 over the past 10 days and 1.36 million over the past 3 months. The company’s latest data on shares outstanding shows there are 88.86 million shares.
The 3.22% of Atyr Pharma Inc’s shares are in the hands of company insiders while institutional holders own 62.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.92 million on 2025-03-14, giving us a short ratio of 3.39. The data shows that as of 2025-03-14 short interest in Atyr Pharma Inc (ATYR) stood at 951.0 of shares outstanding, with shares short rising to 4.35 million registered in 2025-02-14. Current price change has pushed the stock -20.72% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATYR stock continues to rise going into the next quarter.
